Co-Authors
This is a "connection" page, showing publications co-authored by Konstantinos Tsioufis and Dimitrios Tousoulis.
Connection Strength
14.961
-
Correction to: The mystery of "missing" visits in an emergency cardiology department, in the era of COVID-19.; a time-series analysis in a tertiary Greek General Hospital. Clin Res Cardiol. 2020 Dec; 109(12):1490.
Score: 0.916
-
Unveiling the mystery of "missing" emergencies in the era of COVID-19 pandemic: a generalized phenomenon with unclarified implications. Clin Res Cardiol. 2020 Dec; 109(12):1580-1581.
Score: 0.894
-
The mystery of "missing" visits in an emergency cardiology department, in the era of COVID-19.; a time-series analysis in a tertiary Greek General Hospital. Clin Res Cardiol. 2020 Dec; 109(12):1483-1489.
Score: 0.886
-
The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19. Hellenic J Cardiol. 2020 Jan - Feb; 61(1):31-33.
Score: 0.883
-
Biomarkers of Atrial Fibrillation in Hypertension. Curr Med Chem. 2019; 26(5):888-897.
Score: 0.802
-
ConfidenHT™ System for Diagnostic Mapping of Renal Nerves. Curr Hypertens Rep. 2018 05 19; 20(6):49.
Score: 0.768
-
Anti-hypertensive treatment in peripheral artery disease. Curr Opin Pharmacol. 2018 04; 39:35-42.
Score: 0.756
-
The new guidelines for hypertension: Navigating between Scylla and Charybdis of clinical practice. Hellenic J Cardiol. 2020 Mar - Apr; 61(2):127-128.
Score: 0.753
-
SPYRAL HTN-OFF MED study: Renal denervation in the spiral orbits of current results and future studies. Hellenic J Cardiol. 2017 Sep - Oct; 58(5):320-321.
Score: 0.738
-
Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome. J Hypertens. 2017 05; 35(5):1100-1108.
Score: 0.715
-
Hypertension and Heart Failure with Preserved Ejection Fraction: Connecting the Dots. Curr Vasc Pharmacol. 2017; 16(1):15-22.
Score: 0.698
-
Renal Denervation Therapy: Can it Contribute to Better Blood Pressure Control in Hypertension? Curr Vasc Pharmacol. 2017; 16(1):66-69.
Score: 0.698
-
Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand? Curr Vasc Pharmacol. 2017; 16(1):30-43.
Score: 0.698
-
Editorial: Uncontrolled Hypertension and Related Comorbidities: A Clinician's Update. Curr Vasc Pharmacol. 2017; 16(1):3-4.
Score: 0.698
-
Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives. Int J Mol Sci. 2021 Jun 21; 22(12).
Score: 0.238
-
Hypertension and patients with acute coronary syndrome: Putting blood pressure levels into perspective. J Clin Hypertens (Greenwich). 2019 08; 21(8):1135-1143.
Score: 0.208
-
Peritoneal dialysis as a therapeutic solution in elderly patients with cardiorenal syndrome and heart failure: A case-series report. Hellenic J Cardiol. 2020 Mar - Apr; 61(2):73-77.
Score: 0.205
-
Arterial hypertension in patients under antineoplastic therapy: a systematic review. J Hypertens. 2019 05; 37(5):884-901.
Score: 0.205
-
Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations. J Clin Hypertens (Greenwich). 2019 05; 21(5):546-554.
Score: 0.204
-
Biomarkers Associated with Stroke Risk in Atrial Fibrillation. Curr Med Chem. 2019; 26(5):803-823.
Score: 0.201
-
Lowering weight equals reduction of mortality: How far are we from the "Ithaka" of ideal weight control? J Clin Hypertens (Greenwich). 2018 12; 20(12):1674-1675.
Score: 0.198
-
Do we need biomarkers for diabetics progressing to heart failure? Hellenic J Cardiol. 2018 Mar - Apr; 59(2):98-99.
Score: 0.193
-
Cardiovascular morbidity of severe resistant hypertension among treated uncontrolled hypertensives: a 4-year follow-up study. J Hum Hypertens. 2018 07; 32(7):487-493.
Score: 0.191
-
Uric acid as an independent predictor of coronary artery disease in essential hypertension: Data from an 8-year-follow-up study. Clin Exp Pharmacol Physiol. 2018 08; 45(8):866-869.
Score: 0.190
-
Azilsartan and Chlorthalidone-new Powerful Fixed dose Antihypertensive Combination. Curr Hypertens Rev. 2018; 14(1):15-20.
Score: 0.187
-
Should renal color Doppler ultrasonography be a routine test in newly diagnosed hypertensive patient? J Hypertens. 2018 01; 36(1):16-22.
Score: 0.187
-
Heart Rate and Blood Pressure: "Connecting the Dots" in Epidemiology and Pathophysiology. Angiology. 2018 Sep; 69(8):660-665.
Score: 0.186
-
Arterial Hypertension and Health-Related Quality of Life. Front Psychiatry. 2017; 8:270.
Score: 0.186
-
Statins and inflammation in cardiovascular disease. Curr Pharm Des. 2017 Oct 09.
Score: 0.184
-
Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis. J Hypertens. 2017 09; 35(9):1750-1757.
Score: 0.183
-
Exercise capacity and haemodynamic response among 12,327 individuals with cardio-metabolic risk factors undergoing treadmill exercise. Eur J Prev Cardiol. 2017 10; 24(15):1627-1636.
Score: 0.182
-
Modern management of hypertensive emergencies and urgencies: Do we need more technology, paramedics, or physicians? J Clin Hypertens (Greenwich). 2017 07; 19(7):702-703.
Score: 0.181
-
Finding the best ablation strategy for renal denervation: A continuing saga. J Clin Hypertens (Greenwich). 2017 04; 19(4):379-380.
Score: 0.177
-
Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression. J Card Fail. 2008 Aug; 14(6):456-64.
Score: 0.096
-
Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol. 2005 Oct 01; 96(7):946-51.
Score: 0.080
-
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e2013136.
Score: 0.055
-
GLP-1 receptor agonists and cardiovascular outcome trials: An update. Hellenic J Cardiol. 2019 Nov - Dec; 60(6):347-351.
Score: 0.050
-
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017 Nov 11; 390(10108):2160-2170.
Score: 0.046
-
Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Hormones (Athens). 2016 Jan-Mar; 15(1):8-14.
Score: 0.041